Jewell Marcus sold 9,928 shares of Cellebrite DI Ltd. at $10.66 for −$106k on Nov 17, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Global Chief Revenue Officer
Global Chief Revenue Officer
Filed Nov 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$105,840.42Shares × reported price
Shares traded
9,928Ordinary shares, par value NIS 0.00001
Price per share
$10.66Reported price. Read footnotes for ranges.
% of reported position traded
2.4%This security and ownership context
Holdings after
404,345Direct
Trade date
Nov 17, 2026Sell
Filed
Nov 18, 2026, 7:14 AM ET1-day reporting delay
Accession
0001628280-26-074647Code S · Transaction 405203
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 414,273 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

CLBT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLBT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +3.6%1w ago +19%1d ago +4.4%
Returns since7d30d90d180d1y

Footnotes in full

F1: The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.41 to $11.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2026. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $11.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.